Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)

Tallantyre, Emma ORCID: https://orcid.org/0000-0002-3760-6634, Planchon, Sarah M., Howard, Harriet, Mays, John and Frowd, Nadia 2026. Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS). Multiple Sclerosis Journal 32 (7) , pp. 722-736. 10.1177/13524585261449988

[thumbnail of Tallantyre AAM.pdf]
Preview
PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution.

Download (330kB) | Preview
[thumbnail of Supplementary_Material.pdf]
Preview
PDF - Supplemental Material
Available under License Creative Commons Attribution.

Download (157kB) | Preview

Abstract

There is growing support for high-efficacy disease-modifying therapy (DMT) in multiple sclerosis (MS), but escalation (ESC) approaches remain common. To describe decision-making in a pragmatic trial of early high-efficacy treatment (EHT) versus ESC. DELIVER-MS is a multi-center, pragmatic, randomized controlled trial (RCT) with a parallel observational study (OBS), which enrolled treatment-naïve people with RRMS in 31 UK/US sites. Primary outcome was as follows: 36-month brain volume loss according to initial treatment approach (EHT vs. ESC). Stepwise multivariable logistic regression was used to predict participation in RCT versus OBS and choice of EHT versus ESC within the OBS cohort. In total, 816 people with MS were enrolled. Participants declined randomization due to preference for a particular DMT (85%), efficacy concerns (20%), and safety concerns (9%). RCT versus OBS participation was associated with lower relapse rate ( = 0.043) and greater brain parenchymal fraction ( = 0.002). Among 374 in the OBS cohort, 125 (33%) chose ESC and 249 (67%) chose EHT. People commencing EHT had higher education attainment ( < 0.001) and relapse rate ( = 0.025). Baseline DELIVER-MS data demonstrate that participants with milder disease are more likely to participate in RCT. The choice of EHT versus ESC was associated with demographic factors and disease activity. NCT03535298.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Medicine
Additional Information: RRS policy applied. For full list of authors please see article webpage https://doi.org/10.1177/13524585261449988
Publisher: SAGE Publications
ISSN: 1352-4585
Date of First Compliant Deposit: 30 June 2026
Last Modified: 30 Jun 2026 13:00
URI: https://orca.cardiff.ac.uk/id/eprint/187599

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics